INTRODUCTION
Most of what we know about the biochemistry of memory processes has come from pharmacological experiments. We recently published several extensive reviews on this subject in relation to memory consolidation (Izquierdo & McGaugh, 2000; McGaugh & Izquierdo, 2000) , the dichotomy between short-and long-term memory (Izquierdo et al., 1999; , retrieval (Barros et al., 2003) , and extinction .
In addition, several other recent and excellent accounts of special aspects of these subjects have emerged: the role of glutamate receptors in memory processes (Castellano et al., 2001; Riedel et al., 2003) , the molecular pharmacology of extinction (Myers & Davis, 2002) , molecular models of human cognition deficits involving alterations of phosphorylation of the transcription factor cAMPresponse element binding protein (CREB) (Weeber & Sweatt, 2002) , or disruptions of calcium/calmodulin-dependent protein kinase (PK) II activity , the role of the amygdala in consolidation (McIntyre et al., 2003) and extinction (Davis et al., 2003) and others. A recent book edited by Riedel and Platt (2003) contains chapters reviewing most aspects mentioned above and others in detail.
Here we review papers published between mid-2001 and October 2003 on pharmacological findings that shed light on the biochemistry of consolidation, retrieval, and extinction that are (C) 2004 Freund & Pettman, U.K. therefore generally not covered by the articles mentioned above. Topics that are being currently studied in this laboratory, but for which the results are still a long way from becoming definitive, will not be reviewed. These areas include the role of the cellular prion protein (Martins e t al., 2002; Martins et al., 2003) and the role of brain ectonucleotidases in memory processes . The two subjects may be interrelated (Pereira et al., 2001 ).
MEMORY MECHANISMS: A GENERAL VIEW
Pharmacological experiments, often corroborated by studies using genetic manipulation, have established the major molecular mechanisms of memory consolidation and certain mechanisms involved in retrieval and extinction. The most useful studies have usually been carried out using small and slow stereotaxic infusions of drugs into restricted brain areas. The infused material reaches not more than mm of brain tissue and diffuses away from the infusion site with a time constant of 30 min or less (Martin, 1991; Ardenghi et al., 1997;  Barros et al., 2000, 2001) . Larger or faster infusions yield data that are difficult to interpret and will not be commented upon here. In certain instances, systemic administration produced relevant findings, however, depending on the drug chosen.
Most studies have been carried out on the hippocampus, the brain structure most involved in memory processing and/or the main structure responsible for the consolidation, retrieval, and extinction of many tasks in animals and humans (Eichenbaum et al., 1996; Bunsey, 1996 Eichenbaum et al., 1996; Izquierdo & Medina, 1997; McGaugh & Izquierdo, 2000) . In the CA1 region of the rat hippocampus, consolidation processes involve initially the activation of glutamate N-methyl-D-aspartate (NMDA; Morris et al., 1986; Izquierdo et al., 1992) , alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA; Jerusalinsky et al., 1992 Jerusalinsky et al., , 1992 and metabotropic receptors (m-GluRs; Bianchin et al., 1996) , enhanced by the influence of presynaptic /-PKC on the vesicle-mobilizing substrate GAP-43 (Colley & Routtenberg, 1993; Cammarota et al., 1997; Routtenberg, 2000; Paratcha et al., 2000) and by nitric oxide (NO), carbon monoxide (C), and the platelet-activating factor released from the postsynaptic terminal (Izquierdo et al., 1995; Medina & Izquierdo, 1995) with the intervention of PKG; Bemabeu et al., 1996) . At this early stage, the main brake on memory formation is the widespread net of GAB AA receptors acting simultaneously in CA1, amygdala, medial septum, cortex, and other parts of the brain (Izquierdo et al., 1992; Brioni, 1993) .
Right after training, post-synaptic 13-PKC activity Routtenberg, 2000) , PKA (Bemabeu et al., 1997) and calcium/calmodulindependent PK II (CaMKII) activity is enhanced; the latter phosphorylates the GluR1 subunit of the AMPA receptor (Cammarota et al., 1998) . In rat hippocampus, high levels of AMPA binding follow single aversive training experiences (Cammarota et al., 1996) . Protein kinase A, PKC, and CaMKII phosphorylate several substrates. Inhibitors of these enzymes given immediately post-training into the CA1 region of the hippocampus cancel memory consolidation (Izquierdo & Medina, 1997) . Gene expression and protein synthesis at that time are crucial for long-term, but not for short-term memory formation (Igaz et al., 2002) .
In the first hour after training, PKA, PKC, and CaMKII enzyme activity declines and consolidation becomes gradually less sensitive to inhibitors. At that time, however, hippocampal PKA is essential for maintaining short-term memory alive for the next 3 to 5 h . At 2 to 3 h after training, the activity of PKA increases again in CA1 and this--together with a parallel activation of mitogen-activated kinase (MAPK) pathwaysmis essential for longterm memory to become established. This activity depends on the previous activation of NMDA receptors in CA1 by training (Cammarota et al., 2000) and, in the case of PKA, on the preceding immediate post-training PKA peak mentioned above .
The late wave of PKA and extra-cellular signalregulated kinase (ERK) (Matthies, 1989 . One structure is the insular cortex in the case of conditioned taste aversion (Berman & Dudai, 2001 ).
GLUTAMATE RECEPTORS AND RELATED MECHANISMS
The effect on learned behavior of NMDA receptors blockade induced by 2-amino-5-phosphonopentanoic acid (AP5) or its analogs in restricted brain areas is conventionally taken as an indication that such areas are crucially involved in the early stages of memory consolidation (Morris et al., 1986; Izquierdo et al., 1992) . Recently, the blockade of NMDA receptors in the prelimbic cortex was found to induce amnesia for odorreward associative learning (Tronel & Sara, 2003) In addition, the retrograde amnesia induced by AP5 for one-trial avoidance was shown to have a different time course during the onset of its effect, depending on the brain structure into which it is infused: CA1, basolateral amygdala, and entorhinal, posterior parietal, or anterior cingulate cortex (Rosatto et al., 2003) . Thus, it .
Extinction is a form of learning in which animals previously trained to associate a cue (conditioned stimulus, CS) with a reinforcement (unconditioned stimulus, US) are required to associate the cue with the lack of reinforcement; i.e., to change the previous CS-US association into a CS-no US association (Myers & Davis, 2002; Vianna et al., 2003a Vianna et al., , 2003b . The consolidation of extinction requires the transfer from a NMDAindependent to a NMDA-dependent memory (Santini et al., 2001 ). The requirement of NMDA receptors for the extinction of aversive tasks at the time of the first extinction trial has been shown by the use of AP5 in both the amygdala for conditioned startle (Falls et al., 1992) and the hippocampus for one-trial avoidance (Szapiro et al., 2003 ).
The precise synapses at which NMDA receptors participate in consolidation in the hippocampus or elsewhere are generally not known and are vaguely hinted at. For example, the Schaeffer collateral synapses with CA1 (Izquierdo et al., 1992) and the synapses between the mossy fibers and CA3 (Nakazawa et al., 2003) (Wilson & Tonegawa, 1997 (Routtenberg, 1995) .
As shown years ago, both AMPA/kainate receptors (Jerusalinsky et al., 1992) and mGluRs (Bianchin et al., 1994; Riedel, 1996) Medina & Izquierdo, 1995) . The topic was restudied recently in an object-recognition task (Pitsikas et al., 2002) (Walz et al., 2000) showed a marked enhancement of consolidation of one-trial avoidance by the intra-hippocampal infusion of nerve growth factor (NGF); the effect correlated with increased ERK activity near the site of infusion. Two studies (Alonso et al., 2002a,b) have shown that brain-derived neurotrophic factor (BDNF) is critically involved in both the formation of short-term and the long-term memory of one-trial avoidance in the rat, also via the activation of the MAPK pathway in the hippocampus. Noteworthy is that short-term and long-term memory use parallel but largely independent biochemical systems in the hippocampus involving ERK (Izquierdo et al., 1999; Rosatto et al., 2003) .
One study (Johnston & Rose, 2001) Extinction also requires protein synthesis and gene expression in selected brain structures" the hippocampus and the basolateral amygdala for fear conditioning (Vianna et al., , 2003a , and the basolateral amygdala (Bahar et al., 2003) and the insular cortex (Berman & Dudai, 2001) for conditioned taste aversion.
Peripherally administered anisomycin is sufficient for the inhibition of memory consolidation but not necessarily for the inhibition of extinction (Lattal & Abel, 2001) , suggesting that the need for protein synthesis is higher in consolidation than in extinction .
Different from consolidation, extinction needs just one peak of gene expression and protein synthesis at the time of the first test trial without reinforcement; 3 h later, DRB and anisomyein are ineffective .
Sometimes the infusion of anisomycin into the amygdala (Nader et al., 2000; Nader, 2002) , into the hippocampus Debiec et al., 2002), or systemically (Milekic & Alberini, 2002) at the time of retrieval can hinder retrieval in a subsequent test session. This phenomenon is not always seen ), but sometimes is seen using PKA or ERK inhibitors that are given in the hippocampus (Szapiro et al., 2003) .
Such interference has been attributed to the reconsolidation of the original memory by presenting the CS alone. The phenomenon is, as mentioned, not always reproducible and has been denied by certain authors (Myers & Davis, 2002) . Every time that behavioral testing was carried out beyond the second test, a recovery from the retrieval dip of the second test and an inhibition of extinction was observed; so the dip might be just a performance effect Szapiro et al., 2003; Lattal & Abel, 2004) . The observation that retrieval makes memory labile and susceptible to change by, for example, the presentation of novelty Lattal & Abel, 2004 ). This evidence is not sufficient to support the notion implied by the word 'reeonsolidation'.
Exactly which proteins are synthesized in the two peaks that follow the original training or in the single peak that is needed for extinction is not known. Evidence obtained in many studies after one-trail avoidance in the day-old chick (Rose, 1995) and in a similar and other tasks in rodents (Sandi et al., 2003) indicate that glyco-and glycosialo-proteins related to cell adhesion are synthesized by neurons that have recently participated in memory formation, apparently also in two waves. One of the best-known cell adhesion proteins whose synthesis is increased post-training and which is necessary for long-term consolidation is the neural cell adhesion molecule (NCAM) (Rose, 1995) . The NCAM has been recently reported to be an alternative signaling receptor for ligands of the GDNF (glial cell line-derived neurotrophic factor) family (Paratcha et al., 2003) . The GDNF is involved in neurite branching and regeneration, both of which are believed to play a role in long-term memory (Geinisman et al., 2001 ). The exact role of GDNF in learning and memory, however, has not been investigated.
ENZYME INHIBITORS AND CRITICAL PERIODS FOR PROTEIN SYNTHESIS
The two peaks of gene expression and protein synthesis necessary for consolidation and the peak necessary for extinction are accompanied by enhanced activity of PKA and by increased levels of the phosphorylated form of the constitutive transcription factor, CREB (Bemabeu et al., 1997; Taubenfeld et al., 1999) . Simultaneously with those peaks of activity, memory becomes especially sensitive to PKA and ERK (MAPK) inhibitors in the hippocampus (see Izquierdo & McGaugh, 2000) . The (Selcher et al., 2003) .
In areas other than the hippocampus, the ERK inhibitors, U0126 and PD098059, and the PKA inhibitors, Rp-cAMPs and (Locatelli et al., 2002) .
The role of ERKs in the hippocampal circuitry previously described for one-trial avoidance (Walz et al., 1999a,b) was now observed in an object recognition task (Kelly et al., 2003) and in longterm spatial memory (Hebert & Dash, 2002) . In one-trial avoidance, the activity of p42 and p44 increases both after training (Cammarota et al., 2000; and after testing (Szapiro et al., 2000) .
Two other enzymes of the MAPK family have also been investigatednthe c-Jun N-terminal kinase (JNK), and p38MAPK. The intra-CA1 infusion of SP600125, the newly developed inhibitor of JNK, at a dose that reduces c-Jun phosphorylation without affecting ERK1/2 or p38MAPK activity, enhances short-term memory but blocks long-term memory formation and the retrieval of one-trial avoidance in rats (Bevilaqua et al., 2003) . Aside from indicating a multiple role of JNK in memory processes, the results further underline the dichotorny between short-term and long-term memory for this task . In contrast, the post-training intrahippocampal infusion of the specific p38MAPK inhibitor, SB203580, inhibits both short-term and long-term memory formation of this task; the inactive analog, SB202474 has no effect (Alonso et al., 2003) . A role for the p38 MAPK enzyme in the cerebellar vermis in the acquisition of eye-blink conditioning in the rabbit has also been described (Zhen et (Zhu et al., 2003) .
Protein kinase A and ERK are also necessary in the hippocampus (Szapiro et al., 2003) and the basolateral amygdala (Falls et al., 1992; Szapiro et al., 2003) . In addition, CaMKII is necessary in the hippocampus for the extinction of one-trial avoidance (Szapiro et al., 2003) ; in the basolateral amygdala, the role of CaMKII in extinction has not been investigated.
Concerning the role of amygdalar PKA activity in consolidation and extinction, two papers from the same laboratory suggest that in conditioned-taste aversion, things may be different from what has been described in one-trial avoidance in the rat, both concerning extinction (which is enhanced by Rp-cAMPS) and short-term memory, which is unaffected by that drug (Koh et al., 2003) . As conditioned taste aversion appears to be rather atypical, in the sense that it does not seem to have the same molecular requirements for acquisition and extinction as do other aversive tasks, both in the insula (Berman & Dudai, 2001) (Lin et al., 2001; Lin et al., 2003) .
The molecular pharmacology of consolidation of non-associative learning has been little studied over the years, but the results are quite clear.
Long-term habituation learning does require NMDA receptors, protein synthesis, and signaling pathways in the rat hippocampus , and all those plus non-AMPA receptors and protein phosphatase activity in the abdominal ganglion ofAplysia (Ezzedine & Glanzman, 2003 (Schmitt & Hiemke, 2002) .
Muscimol given into the hippocampus impairs contextual retrieval of fear memory after extinction (Corcoran & March, 2001 ). A few years ago, endogenous benzodiazepinelike molecules were described in the brain (De Blas & Sangameswaran, 1986) , and the memoryenhancing effect of flumazenil, an antagonist of brain benzodiazepine receptors at the GABAA receptor complex was described (see Izquierdo & Medina, 1991 (2003) reported that the D4 receptor agonist, PD168077, facilitates memory consolidation of a similar task in mice, which in addition attenuates the amnesic effect of 7-HO-DPAT. Apomorphine is a drug traditionally used to mimic dopamine effects; recently its main metabolite was found to have effects on memory that are be very different from those ofthe parent compound (Picada et Izquierdo, 1986 Izquierdo, , 1988 Giacobini, 2003) , and they play a role in the metabolism of the amyloid-precursor protein (Pakaski & Kasa, 2003) . Imaging studies have measured brain acetylcholinesterase in Alzheimer patients and found a significant reduction in the amygdala (-33%), the hippocampus (-14%), and the neocortex (-20%); the amygdala is known to be a major projection of the brain cholinergic system (Shinotoh et al., 2003) . Increased Alzheimer pathology in Parkinson disease is related to the use of antimuscarinic drugs in the latter . It is interesting to read the twin articles by Francis (2003) (Ferreira et al., 2003) .
Post-training intra-amygdala scopolamine impairs the conditioned place preference brought about by food or by amphetamine (Schroeder & Packard, 2002) and of avoidance learning in an elevated T-maze, in which anxiety is the reinforcement (De-Mello & Carobrez, 2002 (Gold, 2003) . The medial septal nucleus is a site of action for the memory-stimulating effects of oxotremorine and the amnesic effect of scopolamine (see Izquierdo et al., 1992) . Pregnenolone given into this area increases aeetyleholine release in the hippoeampus and improves recognition memory in rats (Damaudery et al., 2003) .
Working memory was hitherto supposed to be regulated mainly by the prefrontal cortex (Goldman-Rakie, 1996) and, at least in part, by the hippoeampus (Olton, 1985 (Porter et al., 2002) . The deleterious effects of cannabinoids on learning and memory processes was first described by Orsingher and Fulginiti in 1970, and recently confirmed by Mishima et al. (2001) .
The deficit of spatial learning caused by delta 9-tetrahydrocannabinol is blocked by the specific CB antagonist, SR241716A (Da & Takahashi, 2002) . Anandamide impairs memory consolidation of one-trial avoidance in mice; pre-exposure to the apparatus reduces the effect. The drug has no effect upon retrieval when given before testing (Costanzi et al., 2003) .
The most important recent finding concerning the endogenous cannabinoid system and memory is the demonstration that this system, probably in the basolateral amygdala, controls the extinction of aversive conditioned responses in the rat (Marsicano et al., 2002) . This aspect should now be studied in relation to the signaling pathways found to regulate extinction in the amygdala and elsewhere (see Vianna et al., 2003a, b) . The amygdala is characterized by a large presence of CB1 receptors, which appear to be in control of local GABAergic transmission (Katona et al., 2001 ).
The CB1 cannabinoid system has also been proposed to play a role in the endogenous defense against excitotoxocity (Marsicano et al., 2003) , in the induction of LTP (Carlson et al., 2002) , and in the mediation of retrograde signaling in the hippocampus (Wilson & Nicoll, 2001 ).
One paper shows that the intrahippocampal infusion ofRC-3095, the bombesin/gastrin-releasing peptide antagonist, impairs inhibitory avoidance in rats (Schroeder & Packard, 2003) . In the day-old chick inhibitory avoidance model, glucose enhances, and the glucose-uptake inhibitor 2-deoxyglucose disrupts memory consolidation.
Using 132 and 133 adrenoceptor blockers, Gibbs and Summers (2002) concluded that the latter receptor subtype could facilitate glucose uptake by brain cells at the time of consolidation. Talley et al. (2002) observed that vagotomy attenuates the enhancement effect of glucose on spontaneous alternation. This point is of interest on two counts. First, the effect of glucose on that task, believed to be regulated almost exclusively by the hippocampus. Second, the suggestion that the glucose effect can be mediated by vagal afferents, such as studied 45 years ago in connection with the regulation of blood pressure (Izquierdo et al., 1959) .
STRESS AND MEMORY
Memory consolidation and retrieval have been known for a long time to be regulated by circulating levels of stress hormones (Izquierdo, 1989) . A lot of work has been done in the past 2 years on this topic. The epinephrine enhancement of human memory consolidation occurs through an interaction with arousal at the time of encoding (Cahill & Alkire, 2003) . Possibly other stress hormones like corticoids, adrenocorticotropin, vasopressin, 13-endorphin (see Izquierdo, 1989) can act similarly. Long ago, Gold and McGaugh (1975) proposed that endogenous stress hormones modulate memory consolidation for experiences that induce their release. Subsequently, Izquierdo (1989) produced evidence showing that these substances actually induce a form of endogenous state dependency for the tasks that released them, or for the effect oftheir systemic administration.
Glucocorticoids have opposite effects on consolidation, which they regularly enhance, and on retrieval, which they consistently impair (Roozendaal, 2002; McAllister-Williams & Rugg, 2002; Hsu et al., 2003) . The consolidation effect is due to an interaction with a 13-adrenoceptor mechanism in the basolateral amygdala involving activation of a cAMP/PKA system (Roozendaal et al., 2002) . The action of glucocorticoids upon retrieval probably involves the hippocampus (Roozendaal et al., 2001; Jezek et al., 2002) with an involvement of the amygdala (Roozendaal et al., 2003) and is accompanied by reduced blood flow in the medial temporal lobe (de Quervain et al., 2003) .
Whereas the influence of glucocorticoids or other stress hormones facilitates memory formation for traumatic or otherwise aversive experiences (Cordero et al., 2002) , the influence of glucocorticoids at the time of retrieval prevents recall of such experiences and therefore protects from the possible development of post-traumatic stress disorder(s) (Schelling, 2002) . Chronic and repeated stress causes hippocampal cell death from the actions of glucocorticoids at their receptors (Sapolsky, 2001 ); this exacerbation of local toxicity is not caused by apoptosis (Roy & Sapolsky, 2002) .
Stress experience and age determine the impairing or enhancing effects of stress and corticoids on retrieval (Yang et al., 2002 ).
Recently we studied the effect of four different stress hormones, ACTH, adrenaline, vasopressin, and 13-endorphin on the retrieval of one-trial avoidance in rats, measured at day or at 3 to 19 months after training--that is, when both memory and animals were young, middle-aged, and old . The animals were trained at the age of 3 months. When given before testing, all four drugs facilitated retrieval. The doses needed day after training were lower than at 3 months. Between 6 and 9 months, the effect of the four hormones changed into a negative influence: all four depressed retrieval. Yet, in animals tested 12 to 19 months after training at the younger age, retrieval again became gradually more and more sensitive to the drugs, and at the oldest age (22 months) and training-test interval (19 months), retrieval was as sensitive to the facilitator effect of the hormones as it was at the age of 3 months. This finding suggests a strong bimodal response of retrieval mechanisms to age and/or training-test intervals and may be related to the higher emotionality and retrieval of emotional responses seen in the young and the old, as compared with middle-aged humans.
Vasopressin has long been known to enhance both memory consolidation and retrieval in rodents (see above and Paban et al., 2003) . The effect on consolidation has not always been reproduced in humans, as a recent failed attempt attests (Gais et al., 2002) (2001) found a task-and time-dependent memory enhancement by dehydroepiandrosterone in a visual categorization task and in one-trial avoidance in the day-old chick. The substance is normally present in the chick brain, which makes the result even more interesting. Androgens given posttraining to ovariectomized rats enhance the memory of a Y-maze, inhibitory avoidance, and object recognition; the effect is unrelated to changes in affective behavior caused by the hormones (Frye & Lacey, 2001) .
In rats, estrogens quickly enhance visual and place memory in rats (Luine et al., 2003 The concept of endogenous state dependency was formulated twenty years ago (Izquierdo, 1984 (Izquierdo, , 1989 (Izquierdo, 1984; Colpaert et al., 2001 ) but also the findings on the molecular pharmacology of retrieval (Barros et al., , 2001 (Barros et al., , 2003 . Enough evidence might not be available to sustain the dual-process hypothesis of retrieval, which is a pity because the hypothesis is sound and worth further exploration.
EXTINCTION: ITS THERAPEUTIC ROLE AND CAN IT BE ENHAN CED?
Acquired fear is at the root of phobias, panic attacks, generalized anxiety, posttraumatic stress disorder, and at least some forms of depression, including that of bipolar disorders (Lee et al., 2002; Beckett, 2002; Rothbaum & Schwartz, 2002) . It 
